StockData
LB Pharmaceuticals Inc logo

LB Pharmaceuticals Inc (LBRX) stock

LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$40.06−0.24 (-0.60%)

Close on Nov 18, 2026Market cap $1.29BP/E –Yield –

LB Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

LB Pharmaceuticals's pe ratio was 0.2× on Jan 30, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jan 30, 20260.2×−0.0
2025Dec 31, 20250.2×–

More LB Pharmaceuticals figures

See a number that looks wrong?